14 research outputs found

    Retinoic acid modulates chromatin to potentiate tumor necrosis factor alpha signaling on the DIF2 promoter

    Get PDF
    Transcriptional activation by nuclear hormone receptors is well characterized, but their cooperation with other signaling pathways to activate transcription remains poorly understood. Tumor necrosis factor alpha (TNFĪ±) and all-trans retinoic acid (RA) induce monocytic differentiation of acute promyelocytic leukemia (APL) cells in a synergistic manner. We used the promoter of DIF2, a gene involved in monocytic differentiation, to model the mechanism underlying the cooperative induction of target genes by RA and TNFĪ±. We show a functional RA response element in the DIF2 promoter, which is constitutively bound by PML/RARĪ± in APL cells. RA stimulates release of corepressors and recruitment of chromatin modifying proteins and additional transcription factors to the promoter, but these changes cause only a modest induction of DIF2 mRNA. Co-stimulation with RA plus TNFĪ± facilitates binding of NF-ĪŗB to the promoter, which is crucial for full induction of transcription. Furthermore, RA plus TNFĪ± greatly enhanced the level of RNA Pol II phosphorylation on the DIF2 promoter, via synergistic recruitment of TFIIH. We propose that RA mediates remodeling of chromatin to facilitate binding of transcription factors, which cooperate to enhance Pol II phosphorylation, providing a mechanism whereby nuclear receptors interact with other signaling pathways on the level of transcription

    Expression of lymphotoxin-Ī±Ī² on antigen-specific T cells is required for DC function

    Get PDF
    During an immune response, activated antigen (Ag)-specific T cells condition dendritic cells (DCs) to enhance DC function and survival within the inflamed draining lymph node (LN). It has been difficult to ascertain the role of the tumor necrosis factor (TNF) superfamily member lymphotoxin-Ī±Ī² (LTĪ±Ī²) in this process because signaling through the LTĪ²-receptor (LTĪ²R) controls multiple aspects of lymphoid tissue organization. To resolve this, we have used an in vivo system where the expression of TNF family ligands is manipulated only on the Ag-specific T cells that interact with and condition Ag-bearing DCs. We report that LTĪ±Ī² is a critical participant required for optimal DC function, independent of its described role in maintaining lymphoid tissue organization. In the absence of LTĪ±Ī² or CD40L on Ag-specific T cells, DC dysfunction could be rescued in vivo via CD40 or LTĪ²R stimulation, respectively, suggesting that these two pathways cooperate for optimal DC conditioning

    Genetic Background and Sex: Impact on Generalizability of Research Findings in Pharmacology Studies

    Get PDF
    Animal models consisting of inbred laboratory rodent strains have been a powerful tool for decades, helping to unravel the underpinnings of biological problems and employed to evaluate potential therapeutic treatments in drug discovery. While inbred strains demonstrate relatively reliable and predictable responses, using a single inbred strain alone or as a background to a mutation is analogous to running a clinical trial in a single individual and their identical twins. Indeed, complex etiologies drive the most common human diseases, and a single inbred strain that is a surrogate of a single genome, or data generated from a single sex, is not representative of the genetically diverse patient populations. Further, pharmacological and toxicology data generated in otherwise healthy animals may not translate to disease states where physiology, metabolism, and general health are compromised. The purpose of this chapter is to provide guidance for improving generalizability of preclinical studies by providing insight into necessary considerations for introducing systematic variation within the study design, such as genetic diversity, the use of both sexes, and selection of appropriate age and disease model. The outcome of implementing these considerations should be that reproducibility and generalizability of significant results are significantly enhanced leading to improved clinical translation

    The Role of Lymphotoxin-beta-Receptor Signaling in Dendritic Cell Function and T Cell Priming.

    No full text
    Early during an immune response, dendritic cells (DC) interact closely with CD4+ T cells, and cross-talk between these cells can come in the form of tumour necrosis factor (TNF) superfamily ligand-receptor interactions. These signals are critical for the maturation, function and survival of DC, and thereby dictate the capacity of DC to prime a robust T cell response. Among these cues, helper T cell-expressed CD40L interaction with DC-expressed CD40 is required to fully mature DC for cross-priming of help-dependent CD8+ T cell responses. The lymphotoxin-beta receptor (LTĪ²R) is another TNF family receptor on DC, and itā€™s ligands LTĪ±1Ī²2 and LIGHT are expressed on activated T cells. Since abrogated LTĪ²R signaling impairs T cell immunity, we have examined whether LTĪ±Ī² represents another possible helper T cell-derived cue for full DC maturation. However the LT pathway controls lymphoid tissue organization and DC homeostasis, a second possible mechanism explaining the necessity of LTĪ²R signaling for T cell immunity. Here we dissect the role of helper T cell-expressed LTĪ²R ligands and DC-intrinsic LTĪ²R signaling, independent of DC homeostasis or lymphoid organization, in DC function and T cell immunity. Absence of LTĪ±1Ī²2 and not LIGHT on helper T cells results in compromised T cell priming by DC ex vivo, and LTĪ²-/- CD4+ T cell responses are impaired in vivo. Ag-specific CD4+ T cell-expressed LTĪ±1Ī²2 and DC-intrinsic LTĪ²R signaling are required for an optimal cytotoxic T lymphocyte (CTL) response in vivo. While CD40 induces IL-12 and is required for CTL function, DC-intrinsic LTĪ²R signaling is necessary for CTL activation and expansion, early up-regulation of CD86 and IFNĪ±/Ī² production. Our results reveal non-redundant roles for distinct TNF family receptors in enabling DC to program different features in Ag-specific CD8+ T cells.Ph

    The Role of Lymphotoxin-beta-Receptor Signaling in Dendritic Cell Function and T Cell Priming.

    No full text
    Early during an immune response, dendritic cells (DC) interact closely with CD4+ T cells, and cross-talk between these cells can come in the form of tumour necrosis factor (TNF) superfamily ligand-receptor interactions. These signals are critical for the maturation, function and survival of DC, and thereby dictate the capacity of DC to prime a robust T cell response. Among these cues, helper T cell-expressed CD40L interaction with DC-expressed CD40 is required to fully mature DC for cross-priming of help-dependent CD8+ T cell responses. The lymphotoxin-beta receptor (LTĪ²R) is another TNF family receptor on DC, and itā€™s ligands LTĪ±1Ī²2 and LIGHT are expressed on activated T cells. Since abrogated LTĪ²R signaling impairs T cell immunity, we have examined whether LTĪ±Ī² represents another possible helper T cell-derived cue for full DC maturation. However the LT pathway controls lymphoid tissue organization and DC homeostasis, a second possible mechanism explaining the necessity of LTĪ²R signaling for T cell immunity. Here we dissect the role of helper T cell-expressed LTĪ²R ligands and DC-intrinsic LTĪ²R signaling, independent of DC homeostasis or lymphoid organization, in DC function and T cell immunity. Absence of LTĪ±1Ī²2 and not LIGHT on helper T cells results in compromised T cell priming by DC ex vivo, and LTĪ²-/- CD4+ T cell responses are impaired in vivo. Ag-specific CD4+ T cell-expressed LTĪ±1Ī²2 and DC-intrinsic LTĪ²R signaling are required for an optimal cytotoxic T lymphocyte (CTL) response in vivo. While CD40 induces IL-12 and is required for CTL function, DC-intrinsic LTĪ²R signaling is necessary for CTL activation and expansion, early up-regulation of CD86 and IFNĪ±/Ī² production. Our results reveal non-redundant roles for distinct TNF family receptors in enabling DC to program different features in Ag-specific CD8+ T cells.Ph

    LTĪ²R signaling in dendritic cells induces a type I IFN response that is required for optimal clonal expansion of CD8+ T cells

    No full text
    During an immune response, antigen-bearing dendritic cells (DCs) migrate to the local draining lymph node and present antigen to CD4+ helper T cells. Antigen-activated CD4+ T cells then up-regulate TNF superfamily members including CD40 ligand and lymphotoxin (LT)Ī±Ī². Although it is well-accepted that CD40 stimulation on DCs is required for DC licensing and cross-priming of CD8+ T-cell responses, it is likely that other signals are integrated into a comprehensive DC activation program. Here we show that a cognate interaction between LTĪ±Ī² on CD4+ helper T cells and LTĪ² receptor on DCs results in unique signals that are necessary for optimal CD8+ T-cell expansion via a type I IFN-dependent mechanism. In contrast, CD40 signaling appears to be more critical for CD8+ T-cell IFNĪ³ production. Therefore, different TNF family members provide integrative signals that shape the licensing potential of antigen-presenting DCs
    corecore